Ever seen a gallstone ‘cork’ the pylorus? Our new @DDS_Journal Image of the Month features a rare Bouveret’s syndrome causing Gastric Outlet Obstruction. Cracked & Cleared with endoscopic electrohydraulic lithotripsy!
🔗 rdcu.be/fnSK6
ALT Overcoming Obstruction: Endoscopic Lithotripsy in Bouveret’s Syndrome
When anatomy is altered and standard tools fail, creativity wins.⭐️@SiddikiGI@JerryDangMD@ridhima_kaul7
Excited to share our @ACGCRJ video case of a migrated plastic pigtail stent after Roux-en-Y gastric bypass.
Using EUS fluoroscopy guidance, bipolar RF scissors enabled precise sinus-tract dissection and successful stent retrieval. #GITwitter@CCF_GIFellows
Honored to be selected as Fellow of the Month by our amazing residents. @CCF_IMCHIEFS
One of the best parts of fellowship has been working with residents and students. Thankful for the opportunity to teach, learn, and work alongside such great residents. #MedEd
We've appointed Miguel Regueiro, MD, as our new Executive Vice President and Enterprise Chief of Staff.
Dr. Regueiro will help shape clinical strategy and lead more than 6,000 physicians and 4,000 advanced practice providers across our health system.
cle.clinic/4vmOGjH
In the midst of all the justifiable excitement, let's not forget that there are people with very limited time waiting desperately to access daraxonrasib. Let's pray @FDAOncology moves as quickly as humanly possible to allow access #ASCO26
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Absolutely practice changing!! One of the most stunning developments in the treatment of patients with metastatic pancreatic cancer !! It is one of the rare moments in oncology which you will always remember ! Like the imatinib, trastuzumab presentations @ASCO#ASCO26@OncoAlert
Do Improving Hepatic Biomarkers Predict Spontaneous Stone Passage? ERCP Yield in Suspected Choledocholithiasis
Pleased to share our latest publication in @DDS_Journal. Thankful for the opportunity to work alongside an outstanding team!
📚: link.springer.com/article/10…
⭐️ Editor Pick of the Month🏆 #ACGCRJ
In obscure GI bleeding, atypical “varices” should prompt consideration of arterial lesions. EUS can bridge the gap between nondiagnostic endoscopy and definitive CTA.
🔗tinyurl.com/eczw3a7v
#ACGCRJ Editor Pick of the Month!
67 👨 with 8 yrs of melena & IDA → multiple negative endoscopies before a bleeding jejunal GIST was found.
📹 VCE: proximal SB bleeding
🔎 Enteroscopy: ulcerated jejunal mass
⚡ APC hemostasis
🩺 Surgery: low-grade GIST
#GITwitter#GIST
"Is a napkin drawing enough?"
What do we actually need from endorobotics?
A room of GI, surgeons, engineers, industry international faculty (Japan, Korea, China, Saudi Arabia). Sept 24, Cleveland. Half-day before CADEC.
clevelandclinicmeded.com/liv…@matthew_kroh@cheryl_dimattia@RitaRys1